期刊文献+

血浆醛固酮水平对急性冠脉综合征患者冠脉病变及预后的预测价值

The Influence of Aldosterone to the Severity of Coronary Artery Lesions and Recent Prognosis in Patients with Acute Coronary Syndrome
下载PDF
导出
摘要 目的:探讨急性冠脉综合征(ACS)患者血浆醛固酮(Aldo)水平对冠状动脉病变严重程度的影响及与患者近期预后的关系。方法:选择2010年1月-2011年1月在本院心内科住院并行冠脉造影检查的ACS患者166例,冠脉造影检查前于升主动脉根部采取血标本,测定醛固酮水平,按醛固酮水平高低分为三组:A组(Aldo<100ng/ml),B组(100ng/ml≤Aldo≤200ng/ml)及C组(Aldo>200ng/ml)。根据冠脉造影结果,分析各组ACS患者醛固酮水平与冠脉病变严重程度的关系;并观察ACS患者经皮腔冠脉内介入治疗(PCI)术前醛固酮水平对术后近期预后(6个月)的影响。结果:三组ACS患者随Aldo水平升高,多支血管病变、冠脉B2/C型病变、冠脉病变狭窄程度积分(Gensini积分)均明显增高,组间差异有统计学意义(P<0.05或P<0.01);多因素Logistic回归分析显示醛固酮是ACS患者PCI术后6个月内MACE发生的独立预测因子。结论:ACS患者血浆醛固酮水平与冠脉病变严重程度相关,醛固酮水平的高低对ACS患者PCI术后的近期预后有预测价值。 Objective: To investigate the influence of serum aldosterone levels to the severity of coronary artery lesions and the recent prognosis in acute coronary syndrome (ACS)patients underwent percutaneous coronary intervention (PCI) .Method: The study included 166 ACS patients admitted in author's department of cardiology from January 2010 to January 2011.All the patients received coronary angiography and were divided into three groups according to aldosterone levels: A group (Aldo〈100 ng/ml ) ; B group ( 100 ng/ml ≤ Aldo ≤200 ng/ml ) ; C group (Aldo〉200 ng/ml ) . Serum aldosterone level was measured and analyzed its relationship with the severity of coronary artery lesions and the recent prognosis of ACS patients underwent PCI.Result: ACS Patients in group with higher Aldo levels had higher incidence rates of muhi-vessel lesions, B2/C type lesions and higher Gensini accumulated points; (2) Multivariaste Logistic regression analyis indicated that serum aldosterone was a srtong independent predictor for incidence rate of major adverse cardiac events ( MACE ) in ACS patients underwent PCI within 6 months.Conclusion: The serum aldosterone level is associated with the severity of coronary artery lesions in ACS patients.Aldoterone level is valuable in predicting the recent prognosis of ACS patients underwent PCI.
出处 《中国医学创新》 CAS 2013年第7期8-10,共3页 Medical Innovation of China
关键词 醛固酮 急性冠脉综合征 血管成形术 经腔 经皮冠状动脉 Aldosterone Acute coronary syndrome Angioplasty Transluminal Percutaneous coronary
  • 相关文献

参考文献9

  • 1吕树铮.2007年冠心病研究回顾(续)[J].中国心血管病研究,2008,6(5):321-323. 被引量:12
  • 2Pitt B, White H, Nicolau J, et al.Eplcrenone reduces mortality 30 days ater randomization following acute myocardial infarction in patients with let ventricular systolic dysfunction amt heart failure[J].J Am Coll Cardiol, 2005, 46 ( 3 ) : 425-431.
  • 3Katayama T, Nakashima H, Furudono S, et al.Evaluation o neurohumoral activation (adrenomedullin, BNP, Caecholamines, etc ) in patients with acute myocardial infarction[J].Intem Med, 2004, 43 ( 11 ) : 1015-1022.
  • 4Beygui F, Collet J P, Benoliel J J, et al.High plasma aldostrone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial inarction[J].Circulation, 2006, 114 ( 1 ) : 2604-2610.
  • 5Vantrimpont P, Rouleau J L, Ciampi A, et al.Two-year time course and signiicance of neurohumoral activation in the Survival and Ventricular Enlargement( SAVE ) Study[J].Eur Heart J, 1998,19( 10 ): 1552-1563.
  • 6Jafe I Z, Mendelsohn M E.Angiotensin Ⅱ and Aldosterone regulate gene transcription via functional mineralocortoeoid receptors in human coronary artery smooth muscle cells[J].Cire Res, 2005, 96 ( 6 ) : 643-650.
  • 7Brown N J, Kim K S, Chen Y Q, et al.Synergistic effects of adrenal steroids and angiotensin lion plasminogen activator inhibitor-I production[J].J Clin Endocrinot Metab, 2000, 85 ( 1 ) : 336-344.
  • 8袁军,贾汝汉,包艳,丁国华.活性氧和转化生长因子β1在醛固酮上调纤溶酶原激活物抑制剂1中的作用[J].中华肾脏病杂志,2006,22(12):758-762. 被引量:8
  • 9Hayashi M, Tsutamoto T, Wada A, et al.Relationship between transcardiac extraction of Aldosterone and let ventricular remodeling in patients with first acute myocardial infaction extracting Aldosterone through heart promotes ventricular remodeling after acute myocardial infarction[J].J Am Coil Cardiol, 2001, 38 ( 5 ) : 1375-1382.

二级参考文献17

  • 1姜宗培,余学清,陈雄辉,杨念生,河宪珠,李熙渤.转化生长因子β1对系膜细胞纤溶酶原激活物抑制物1表达的影响[J].中华肾脏病杂志,2004,20(4):260-263. 被引量:11
  • 2Browa NJ, Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens,2005,14:235-241.
  • 3Epstein M. Aldosterone as a mediator of progressive renal dysfunction: evolving perspectives. Intern Med,2001,40:573-583.
  • 4Ha H, Lee HB. Beactive oxygen species and matrix remodeling in diabetic kidney. J Am Soc Nephrol,2003,14(8 Suppl 3):S246-S249.
  • 5Lee HB, Yu MB. Yang Y, et al. Reactive oxygen speciesregulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol, 2003,14(8 Suppl 3):S241-S245.
  • 6Kagami S, Kuhara T, Okada K, et al. Dual effects of angiotensin Ⅱ on the plasminogen/plasmin system in rat mesangial cells. Kidney Int, 1997,51:664-671.
  • 7Hagiwara H, Kaizu K, Uriu K, et al. Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models. Thromb Res, 2003, 111:301-309.
  • 8Eddy AA. Plasminogen activator inhibitor-1 and the kidney.Am J Physiol Renal Physiol, 2002, 283 :F209-F220.
  • 9Ma J, Weisberg A, Griffin JP, et al. Plasminogen activator inhibitor- 1 deficiency protects against aldosterone-induced glomerular injury. Kidney Int, 2006, 69:1064-1072.
  • 10Rerolle JP, Hertig A, Nguyen G, et al. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int, 2000, 58:1841-1850.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部